anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Matinas BioPharma · pitchdeck

Matinas BioPharma | Investor Presentation Deck | 29 slides

29 pages · 4 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Matinas BioPharma | Investor Presentation Deck | 29 slides

Matinas BioPharma · 2024-01
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 23 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem (Identify pain) 8 slides 100% 8/8 slides 100% 8/8 slides · 44 hits
— 0/8 slides
37.5% 3/8 slides · 6 hits 50% 4/8 slides 100% 8/8 slides · 16 hits 100% 8/8 slides Agitate (Make it worse) 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits
— 0/1 slides
100% 1/1 slides · 2 hits
— 0/1 slides
100% 1/1 slides · 3 hits 100% 1/1 slides Solution (Provide relief) 10 slides 100% 10/10 slides 100% 10/10 slides · 54 hits
— 0/10 slides
40% 4/10 slides · 7 hits 50% 5/10 slides 100% 10/10 slides · 18 hits 100% 10/10 slides Impact & Next Steps 4 slides 100% 4/4 slides 100% 4/4 slides · 24 hits
— 0/4 slides
50% 2/4 slides 25% 1/4 slides 100% 4/4 slides
— 0/4 slides

Slide inventory

29
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
The slide uses a two-column layout to contrast a specific lead asset (MAT2203) with broader pipeline opportunities.present_solution
Open slide detail
04
The slide uses a combination of molecular diagrams and bulleted benefits to explain the LNC technology.present_solution
Open slide detail
05
The slide uses a two-part framework: Targeting (left) and Delivery (right).present_solution
Open slide detail
06
transition
Open slide detail
07
Uses authority-citation framework to build urgency by aggregating external validation from reputable news and scientific sources.argue_timing
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
08
Uses a before-after-bridge style logic to frame the solution.present_solution
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
09
The slide uses a process flow diagram to map clinical outcomes to specific trial metrics.show_traction
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
10
This is a citation slide showcasing scientific validation of the company's technology.show_traction
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
11
The slide uses a human silhouette as a central diagram to map specific fungal pathogens and resulting conditions to anatomical locations.show_traction
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
12
Focuses on clinical success in a compassionate use setting.show_traction
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
13
The slide uses a timeline-based case study format to demonstrate clinical efficacy and safety.illustrate_case
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
14
The slide highlights both the clinical urgency (toxicity, resistance) and the commercial potential (orphan disease status).frame_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
15
Focuses on clinical trial strategy and regulatory milestones.plan_implementation
Open slide detailBeat · Solution (Provide relief)Loop · Quick Win Big Bet
16
The slide outlines the randomization, treatment arms, timeline, patient population criteria, and primary/secondary endpoints.plan_implementation
Open slide detailBeat · Solution (Provide relief)Loop · Quick Win Big Bet
17
Uses a combination of an additive equation for the value prop and a chevron-based timeline for the life cycle management.present_solution
Open slide detailBeat · Solution (Provide relief)Loop · Quick Win Big Bet
18
transition
Open slide detail
19
The slide uses a matrix-like structure to map disease areas (Infection, Inflammation, Oncology) to specific animal models and clinical indications.show_traction
Open slide detail
20
Uses a chevron-based process flow to represent maturity stages.plan_implementation
Open slide detail
21
The chart shows dose-response curves where LNC formulations consistently outperform Taxol.show_traction
Open slide detail
22
The slide uses a timeline diagram to explain the experimental design and a line chart to show tumor volume reduction over time.show_traction
Open slide detail
23
The study is an ex-vivo human whole blood study using 80 ug/mL LNC and 512 ng/mL Cy5-labeled siRNA cargo.show_traction
Open slide detail
24
The slide compares LNC formulations against IMQ-only and IL-17A antibody controls.analyze_data
Open slide detail
25
Includes study design details (n=55, female C57BL/6 mice) and statistical significance markers for treatment groups.analyze_data
Open slide detail
26
show_traction
Open slide detailBeat · Impact & Next Steps
27
The slide uses a three-column icon-based layout to summarize key IP milestones.present_solution
Open slide detailBeat · Impact & Next Steps
28
The slide uses a grid layout to display headshots and names for the executive team, and a list format for the board of directors with associated company logos.other
Open slide detailBeat · Impact & Next Steps
29
The slide combines a financial summary with a timeline of milestones and a value proposition for their lead asset.plan_implementation
Open slide detailBeat · Impact & Next Steps